Effect of a Driving Pressure Adjustment Procedure for High-Frequency Jet Ventilation in Patients Undergoing Tumor Thermal Ablation in Interventional Radiology
Pulmojet 3
1 other identifier
interventional
560
1 country
7
Brief Summary
Tumor thermal ablation under Jet Ventilation is a procedure performed under general anesthesia that enables tumor ablation under radiological imaging guidance. This procedure, being less invasive than conventional surgery, allows for a faster recovery and hospital discharge. This procedure requires significant precision to ensure the most complete destruction of the tumor, while also preserving adjacent organs. During general anesthesia, respiratory movements complicate radiological localization and tumor destruction. The principle of High-Frequency Jet Ventilation (HFJV) involves using a device that ventilates a small volume of air and oxygen at a specific pressure, called driving pressure, at a high frequency. This ventilation mode reduces respiratory movements while ensuring continuous ventilation and oxygenation. This respiratory stability allows for the precision necessary to superimpose images for tumor localization and destruction. There are no guidelines regarding the driving pressure setting for HFJV for tumor thermal ablation. The method tested in this research is based on patient's height to optimize the driving pressure when using HFV. The main objective of this research is to evaluate the impact of driving pressure settings, on respiratory function, taking into account patient's height. On the day of the procedure, the driving pressure setting for the HFJV will be randomly assigned (1.4 bars, 1.9 bars, 2.4 bars, or customized according to the patient's height) (1 bar = 14 psi). The research will be conducted using medical data collected during routine patient care. Patient participation will last for the duration of their hospital stay, approximately two days.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Mar 2026
Typical duration for not_applicable
7 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 21, 2026
CompletedFirst Posted
Study publicly available on registry
February 13, 2026
CompletedStudy Start
First participant enrolled
March 13, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 13, 2028
ExpectedStudy Completion
Last participant's last visit for all outcomes
March 13, 2028
March 27, 2026
March 1, 2026
2 years
January 21, 2026
March 26, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Efficacy on respiratory function of a personalized strategy for adjusting the driving pressure of the HFJV
Occurrence of at least one of the following events : * Absolute change in FetCO2 of 8 mmHg between the baseline (T0) and the end of HFJV (T1), And/or * FetCO2 ≥ 45 mmHg at the end of the procedure, And/or * SpO2 \< 94% at the end of the procedure, And/or * Interruption of HFJV before the end of the procedure due to SpO2 ≤ 90%.
Immediately after the procedure
Secondary Outcomes (14)
Efficiency of the personalized setting compared to a fixed setting of 1.4 bars
Immediately after the procedure
Efficiency of the personalized setting compared to a fixed setting of 1.9 bars
Immediately after the procedure
Efficiency of the personalized setting compared to a fixed setting of 2.4 bars
Immediately after the procedure
Efficiency for each of the four events comprising the composite criterion of the customized setting compared to all three other groups
Immediately after the procedure
Efficiency for each of the four events comprising the composite criterion, of the customized setting compared to a fixed setting of 1.4 bars
Immediately after the procedure
- +9 more secondary outcomes
Study Arms (4)
Driving pressure with a fixed setting of 1.4 bars
ACTIVE COMPARATOROn the day of the interventional radiology surgery (Day 0), the driving pressure setting will be of 1.4 bars.
Driving pressure with a fixed setting of 1.9 bars
ACTIVE COMPARATOROn the day of the interventional radiology surgery (Day 0), the driving pressure setting will be of 1.9 bars.
Driving pressure with a fixed setting of 2.4 bars
ACTIVE COMPARATOROn the day of the interventional radiology surgery (Day 0), the driving pressure setting will be of 2.4 bars.
Driving pressure with a personalized setting
EXPERIMENTALOn the day of the interventional radiology surgery (Day 0), the driving pressure setting will be personalized according to the patient's height : 1.4 bars if patient's height \< 150 cm, 1.6 bars if patient's height is between 150 cm and 160 cm, 1.8 bars if patient's height is between 161 cm and 170 cm, 2.0 bars if patient's height is between 171 cm and 180 cm, 2.2 bars if patient's height is between 181 cm and 190 cm and 2.4 bars if patient's height \> 190 cm
Interventions
High-Frequency Jet Ventilation (HFJV) involves ventilating with a small tidal volume of gas at a high frequency, ensuring diaphragmatic stability. This stability allows for the precise superimposition of localization and puncture images. HFJV is defined as a ventilation mode with very high insufflation rates (120 to 200 cycles per minute) delivering a low tidal volume through a catheter with a gauge of 13G to 16G.
Eligibility Criteria
You may qualify if:
- Age ≥ 18 years.
- Patient undergoing thermal ablation of a solid tumor under HFJV.
- Patient who has given their consent.
- Patient covered by a social security scheme.
You may not qualify if:
- Patient under guardianship or curatorship.
- Patient who does not understand French.
- Pregnant and breastfeeding woman
- Patient who has had a pneumonectomy
- Patient requiring an endotracheal tube smaller than 6.5
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (7)
CHU de Lyon
Lyon, 69002, France
Centre Léon Bérard
Lyon, 69008, France
CHU de Nantes
Nantes, 44093, France
CHU de Nîmes
Nîmes, 30900, France
CHU de Poitiers
Poitiers, 86000, France
ICO Unicancer
Saint-Herblain, 44800, France
Institut Gustave Roussy
Villejuif, 94800, France
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 21, 2026
First Posted
February 13, 2026
Study Start
March 13, 2026
Primary Completion (Estimated)
March 13, 2028
Study Completion (Estimated)
March 13, 2028
Last Updated
March 27, 2026
Record last verified: 2026-03